Scientific
MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis
These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.
MK5 Proteome Network Type I Analysis

Type 1 network in which we propagated the absolute log regulation ratio abs(log(r/g)). We used the filtered lowest boundary of the confidence interval for the microarray measurement based and used the high confidence interaction map. Because type-I networks tend to favour highly connected proteins we tested a normalisation scheme in which we would run the network once with real values (the measured column) and once with simulated values where each measured point is set to 1 instead of the actual signal (the expected column). Afterwards we divided the measured value by the expected value. This normalisation scheme works to a certain extend but will lead to a variance that is directly related to the connectivity of each protein. In the end we dropped the use of Type-I networks due to the many technical problems they pose.
Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Gene Rank description measured expected final Hugo
Results: HTML CSV LaTeX
Showing element 852 to 901 of 3206 in total

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
measured\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
expected\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
final\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
Hugo\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
852\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
KINESIN-LIKE PROTEIN KIF13B (KINESIN-LIKE PROTEIN GAKIN). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0651843\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.250194\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.260535025\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
853\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CHROMOSOME 11 OPEN READING FRAME2; CHROMOSOME  11 OPEN READING FRAME2. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.22504\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.863762\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.260534731\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
C11orf2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
854\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
KINESIN-LIKE PROTEIN KIF13A (KINESIN-LIKE PROTEIN RBKIN). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0796144\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.305581\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.260534523\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
KIF13A\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
855\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 6 (IL-4 STAT). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.347585\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.3344\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.260480366\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
STAT6\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
856\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 3 (ACUTE-PHASE RESPONSE FACTOR). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.333707\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.28119\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.260466441\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
STAT3\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
857\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 4. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.333006\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.2785\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.260466171\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
STAT4\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
858\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 1-ALPHA/BETA (TRANSCRIPTION FACTOR ISGF-3 COMPONENTS P91/P84). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.331884\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.2742\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.260464605\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
STAT1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
859\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
U4/U6 SMALL NUCLEAR RIBONUCLEOPROTEIN PRP4 (U4/U6 SNRNP 60 KDA PROTEIN) (WD SPLICING FACTOR PRP4) (HPRP4). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0530266\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.203611\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.26043092\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
PRPF4\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
860\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN K (HNRNP K) (DC-STRETCH BINDING PROTEIN) (CSBP) (TRANSFORMATION UPREGULATED NUCLEAR PROTEIN) (TUNP). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.35663\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.36939\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.260429826\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
HNRPK\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
861\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
TWINKLE; LIKELY ORTHOLOG OF MOUSE T7 GP4-LIKE PROTEIN WITH INTRAMITOCHONDRIAL NUCLEOID LOCALIZATION. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.176631\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.678587\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.260292343\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
PEO1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
862\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.0441578\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.169647\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
0.260292254\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
PYROXD1\vspace{3pt}}\\\cline{1-2}\cline{6-6}
\parbox{\wcA}{\vspace{3pt}\noindent
863\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"RABAPTIN, RAB GTPASE BINDING EFFECTOR PROTEIN 1; RABAPTIN-5; NEUROCRESCIN. \vspace{3pt}}&&&&\parbox{\wcF}{\vspace{3pt}\noindent
RABEP1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
864\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
40S RIBOSOMAL PROTEIN S30. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.124733\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.479216\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.26028555\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
FAU\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
865\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"PRESYNAPTIC PROTEIN SAP97 (SYNAPSE-ASSOCIATED PROTEIN 97) (DISCS, LARGE HOMOLOG 1) (HDLG). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.16564\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.636381\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.260284327\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
DLG1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
866\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"CHANNEL ASSOCIATED PROTEIN OF SYNAPSE-110 (CHAPSYN-110) (DISCS, LARGE HOMOLOG 2). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.141754\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.544635\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.260273394\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
DLG2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
867\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"PRESYNAPTIC PROTEIN SAP102 (SYNAPSE-ASSOCIATED PROTEIN 102) (NEUROENDOCRINE-DLG) (NE-DLG) (DISCS, LARGE HOMOLOG 3). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.138045\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.530387\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.260272216\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
DLG3\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
868\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"PRESYNAPTIC DENSITY PROTEIN 95 (PSD-95) (DISCS, LARGE HOMOLOG 4) (POSTSYNAPTIC DENSITY-95). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.138678\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.53282\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.260271762\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
DLG4\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
869\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
HOMEOBOX PROTEIN BARH-LIKE 1. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.139848\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.537326\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.260266579\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
BARX1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
870\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
T-CELL LEUKEMIA HOMEOBOX PROTEIN 2 (HOMEOBOX PROTEIN HOX-11L1) (NEURAL CREST HOMEOBOX PROTEIN). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0368198\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.14147\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.260265781\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
TLX2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
871\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
T-CELL LEUKEMIA HOMEOBOX PROTEIN 3 (HOMEOBOX PROTEIN HOX-11L2). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0457909\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.175939\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.260265774\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
TLX3\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
872\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
OPSIN 4 (MELANOPSIN). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0585668\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.225027\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.260265657\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
OPN4\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
873\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
T-CELL LEUKEMIA HOMEOBOX PROTEIN 1 (HOMEOBOX PROTEIN HOX-11) (TCL-3 PROTO-ONCOGENE). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0374306\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.143817\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.260265476\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
TLX1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
874\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
HECT DOMAIN CONTAINING PROTEIN 1 (FRAGMENT). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0211489\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.081259\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.260265324\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
HECTD1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
875\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
HOMEOBOX PROTEIN BARH-LIKE 2. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.109193\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.419545\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.260265287\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
BARX2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
876\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
U6 SNRNA-ASSOCIATED SM-LIKE PROTEIN LSM5. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.196219\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.754024\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.260229117\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
LSM5\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
877\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
T54 PROTEIN. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.314497\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.20911\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.260106194\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
GPKOW\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
878\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PUTATIVE PRE-MRNA SPLICING FACTOR RNA HELICASE (ATP-DEPENDENT RNA HELICASE #3) (DEAH-BOX PROTEIN 16). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.039713\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.15268\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.260106104\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
879\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1.02292\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3.93312\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.260078513\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
ARRDC2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
880\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
DYNAMIN 1-LIKE PROTEIN ISOFORM 3; DYNAMIN-LIKE PROTEIN. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.121609\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.467587\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.260077804\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
DNM1L\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
881\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"PHOSPHOINOSITIDE-3-KINASE, CLASS 2, ALPHA POLYPEPTIDE; C2-CONTAINING PHOSPHATIDYLINOSITOL KINASE. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0345092\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.132688\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.260077776\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
PIK3C2A\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
882\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PHOSPHATIDYLINOSITOL-4-PHOSPHATE 3-KINASE C2 DOMAIN-CONTAINING GAMMA POLYPEPTIDE (EC 2.7.1.154) (PHOSPHOINOSITIDE 3-KINASE-C2-GAMMA) (PTDINS-3-KINASE C2 GAMMA) (PI3K-C2GAMMA). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0242456\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.0932247\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.260076997\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
PIK3C2G\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
883\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PHOSPHATIDYLINOSITOL-4-PHOSPHATE 3-KINASE C2 DOMAIN-CONTAINING BETA POLYPEPTIDE (EC 2.7.1.154) (PHOSPHOINOSITIDE 3-KINASE-C2-BETA) (PTDINS-3-KINASE C2 BETA) (PI3K-C2BETA) (C2-PI3K). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0265832\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.102213\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.260076507\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
PIK3C2B\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
884\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SCRIBBLE. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.163652\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.629348\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.260034194\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
SCRIB\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
885\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
LAP (LEUCINE-RICH REPEATS AND PDZ) AND NO PDZ PROTEIN. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.122677\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.471848\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.259992625\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
LRRC1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
886\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
KINESIN HEAVY CHAIN ISOFORM 5C (KINESIN HEAVY CHAIN NEURON-SPECIFIC 2). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.152626\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.587298\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.25987829\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
KIF5C\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
887\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
KINESIN LIGHT CHAIN 2 (KLC 2). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.527178\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2.02856\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.259877943\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
KLC2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
888\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
EXOCYST COMPLEX COMPONENT SEC3 (BM-012). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0775579\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.29844\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.259877697\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
EXOC1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
889\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
NEURONAL KINESIN HEAVY CHAIN (NKHC) (KINESIN HEAVY CHAIN ISOFORM 5A) (KINESIN HEAVY CHAIN NEURON-SPECIFIC 1). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.131576\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.5063\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.259877543\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
KIF5A\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
890\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
TRANSCRIPTION FACTOR IIIA (FACTOR A) (TFIIIA). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0755679\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.290783\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.259877297\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
GTF3A\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
891\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RHO-GTPASE-ACTIVATING PROTEIN 8. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0962556\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.370389\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.259877048\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
PRR5\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
892\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0770577\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.296516\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.259877039\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
TMEM53\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
893\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RHO-GTPASE-ACTIVATING PROTEIN 1 (GTPASE-ACTIVATING PROTEIN RHOOGAP) (RHO-RELATED SMALL GTPASE PROTEIN ACTIVATOR) (CDC42 GTPASE-ACTIVATING PROTEIN) (P50-RHOGAP). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.119625\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.460314\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.259876954\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
ARHGAP1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
894\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
KINESIN HEAVY CHAIN (UBIQUITOUS KINESIN HEAVY CHAIN) (UKHC). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.131086\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.504416\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.259876768\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
KIF5B\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
895\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
KINESIN LIGHT CHAIN 1 (KLC 1). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.684483\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2.63388\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.259876304\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
KLC1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
896\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.161768\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.623248\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.259556388\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
PRPF38B\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
897\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
VACUOLAR PROTEIN SORTING 18 (HVPS18). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.21331\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.821874\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.259541\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
VPS18\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
898\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
WILMS' TUMOR 1-ASSOCIATING PROTEIN (WT1-ASSOCIATED PROTEIN). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0746561\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.287738\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.259458605\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
WTAP\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
899\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SIGNAL RECOGNITION PARTICLE 68 KDA PROTEIN (SRP68). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.193159\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.744637\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.259400218\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
SRP68\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
900\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0403612\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.155595\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.259399081\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
TEX9\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
901\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SPLICING FACTOR ARGININE/SERINE-RICH 11 (ARGININE-RICH 54 KDA NUCLEAR PROTEIN) (P54). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.148259\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.571608\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.259371807\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
SFRS11\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Hugo is the bloody hugo identifier as demanded by the BMC Bioinformatics idiots
- http://analysis.yellowcouch.org/